Literature DB >> 23597400

On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7.

Cory D Rillahan1, Erik Schwartz, Christoph Rademacher, Ryan McBride, Janani Rangarajan, Valery V Fokin, James C Paulson.   

Abstract

The Siglec family of sialic acid-binding proteins are differentially expressed on white blood cells of the immune system and represent an attractive class of targets for cell-directed therapy. Nanoparticles decorated with high-affinity Siglec ligands show promise for delivering cargo to Siglec-bearing cells, but this approach has been limited by a lack of ligands with suitable affinity and selectivity. Building on previous work employing solution-phase sialoside library synthesis and subsequent microarray screening, we herein report a more streamlined 'on-chip' synthetic approach. By printing a small library of alkyne sialosides and subjecting these to 'on-chip' click reactions, the largest sialoside analogue library to date was generated. Siglec-screening identified a selective Siglec-7 ligand, which when displayed on liposomal nanoparticles, allows for targeting of Siglec-7(+) cells in peripheral human blood. In silico docking to the crystal structure of Siglec-7 provides a rationale for the affinity gains observed for this novel sialic acid analogue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597400      PMCID: PMC3751994          DOI: 10.1021/cb400125w

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  25 in total

1.  The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design.

Authors:  Helen Attrill; Hirokazu Takazawa; Simone Witt; Soerge Kelm; Rainer Isecke; Reinhard Brossmer; Takayuki Ando; Hideharu Ishida; Makoto Kiso; Paul R Crocker; Daan M F van Aalten
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

2.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.

Authors:  Vsevolod V Rostovtsev; Luke G Green; Valery V Fokin; K Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2002-07-15       Impact factor: 15.336

3.  Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b.

Authors:  Helen Attrill; Akihiro Imamura; Ritu S Sharma; Makoto Kiso; Paul R Crocker; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2006-08-08       Impact factor: 5.157

4.  High resolution crystal structures of Siglec-7. Insights into ligand specificity in the Siglec family.

Authors:  Magnus S Alphey; Helen Attrill; Paul R Crocker; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

5.  Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.

Authors:  G Nicoll; J Ni; D Liu; P Klenerman; J Munday; S Dubock; M G Mattei; P R Crocker
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

6.  Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

Authors:  Ola Blixt; Steve Head; Tony Mondala; Christopher Scanlan; Margaret E Huflejt; Richard Alvarez; Marian C Bryan; Fabio Fazio; Daniel Calarese; James Stevens; Nahid Razi; David J Stevens; John J Skehel; Irma van Die; Dennis R Burton; Ian A Wilson; Richard Cummings; Nicolai Bovin; Chi-Huey Wong; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Click and pick: identification of sialoside analogues for siglec-based cell targeting.

Authors:  Cory D Rillahan; Erik Schwartz; Ryan McBride; Valery V Fokin; James C Paulson
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

8.  Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin.

Authors:  Nathan R Zaccai; Katsumi Maenaka; Taeko Maenaka; Paul R Crocker; Reinhard Brossmer; Sørge Kelm; E Yvonne Jones
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

9.  Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

Authors:  Yuzuru Ikehara; Sanae Kabata Ikehara; James C Paulson
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

10.  Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.

Authors:  Ingo P Korndörfer; Gerald Beste; Arne Skerra
Journal:  Proteins       Date:  2003-10-01
View more
  14 in total

1.  Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

Authors:  Cory D Rillahan; Matthew S Macauley; Erik Schwartz; Yuan He; Ryan McBride; Britni M Arlian; Janani Rangarajan; Valery V Fokin; James C Paulson
Journal:  Chem Sci       Date:  2014-06-01       Impact factor: 9.825

Review 2.  Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.

Authors:  Takashi Angata; Corwin M Nycholat; Matthew S Macauley
Journal:  Trends Pharmacol Sci       Date:  2015-10       Impact factor: 14.819

Review 3.  Glycomaterials for probing host-pathogen interactions and the immune response.

Authors:  Mia L Huang; Christopher J Fisher; Kamil Godula
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

4.  Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation.

Authors:  Norihito Kawasaki; Cory D Rillahan; Tan-Yun Cheng; Ildiko Van Rhijn; Matthew S Macauley; D Branch Moody; James C Paulson
Journal:  J Immunol       Date:  2014-07-07       Impact factor: 5.422

5.  Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy.

Authors:  Senlian Hong; Chenhua Yu; Peng Wang; Yujie Shi; Weiqian Cao; Bo Cheng; Digantkumar G Chapla; Yuanhui Ma; Jie Li; Emily Rodrigues; Yoshiki Narimatsu; John R Yates; Xing Chen; Henrik Clausen; Kelly W Moremen; Matthew Scott Macauley; James C Paulson; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-14       Impact factor: 15.336

6.  Terminal Epitope-Dependent Branch Preference of Siglecs Toward N-Glycans.

Authors:  Shuaishuai Wang; Congcong Chen; Minhui Guan; Ding Liu; Xiu-Feng Wan; Lei Li
Journal:  Front Mol Biosci       Date:  2021-04-29

7.  Modulation of immune cell reactivity with cis-binding Siglec agonists.

Authors:  Corleone S Delaveris; Shannon H Chiu; Nicholas M Riley; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

8.  Cell-based glycan arrays for probing glycan-glycan binding protein interactions.

Authors:  Jennie Grace Briard; Hao Jiang; Kelley W Moremen; Matthew Scott Macauley; Peng Wu
Journal:  Nat Commun       Date:  2018-02-28       Impact factor: 14.919

Review 9.  Siglec Ligands.

Authors:  Anabel Gonzalez-Gil; Ronald L Schnaar
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

10.  CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.

Authors:  Naoko Matsubara; Akihiro Imamura; Tatsuya Yonemizu; Chizuru Akatsu; Hongrui Yang; Akiharu Ueki; Natsuki Watanabe; Hajjaj Abdu-Allah; Nobutaka Numoto; Hiromu Takematsu; Shinobu Kitazume; Thomas F Tedder; Jamey D Marth; Nobutoshi Ito; Hiromune Ando; Hideharu Ishida; Makoto Kiso; Takeshi Tsubata
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.